Abstract
Bariatric surgery is increasingly performed in morbidly obese HIV patients. Limited data exist regarding antiretroviral drug exposure after bariatric surgery. We report a case of a morbidly obese HIV patient who underwent sleeve gastrectomy. Abacavir, lamivudine, and dolutegravir therapeutic drug monitoring was performed at several time points pre- and postsurgery. Significantly increased levels were measured, particularly for abacavir, whose levels increased ~12-fold. Several mechanistic explanations for these findings are discussed.
Original language | American English |
---|---|
Article number | e02453-19 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 64 |
Issue number | 4 |
DOIs | |
State | Published - 1 Jan 2020 |
Keywords
- Antiretrovirals
- Bariatric surgery
- Obesity
- Sleeve gastrectomy
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases